ID: ALA4786238

Max Phase: Preclinical

Molecular Formula: C21H19N3O4

Molecular Weight: 377.40

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C(c1nc(-c2ccc(OC)cc2)no1)C1(O)C(=O)N(CC)c2ccccc21

Standard InChI:  InChI=1S/C21H19N3O4/c1-4-24-17-8-6-5-7-16(17)21(26,20(24)25)13(2)19-22-18(23-28-19)14-9-11-15(27-3)12-10-14/h5-12,26H,2,4H2,1,3H3

Standard InChI Key:  NILMEAHFCMEONW-UHFFFAOYSA-N

Associated Targets(Human)

HFF-1 186 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trypanosoma cruzi 99888 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Leishmania infantum 5912 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 377.40Molecular Weight (Monoisotopic): 377.1376AlogP: 3.01#Rotatable Bonds: 5
Polar Surface Area: 88.69Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.90CX Basic pKa: CX LogP: 3.32CX LogD: 3.32
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.74Np Likeness Score: -0.91

References

1. Fernandes FS,Santos H,Lima SR,Conti C,Rodrigues MT,Zeoly LA,Ferreira LLG,Krogh R,Andricopulo AD,Coelho F.  (2020)  Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids.,  201  [PMID:32590115] [10.1016/j.ejmech.2020.112418]

Source